Prostate Cancer Metastatic

• CLINICAL_TRIALS trial_result · 2026-08-24
  Clinical Trial Results: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]

  A phase 1/2 trial evaluating talazoparib in combination with temozolomide in prostate cancer has been terminated with posted results.

• CLINICAL_TRIALS research · 2026-01-21
  Clinical Trial Update: A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 [Phase 1, Phase 2]

  A Phase 1b/2 clinical trial evaluating the monoclonal antibody OM-RCA-01 in metastatic tumors expressing FGFR1 is currently recruiting acros…

• CLINICAL_TRIALS trial_result · 2022-12-20
  Clinical Trial Update: The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer [Phase 2]

  Phase 2 clinical trial assessing 68Ga-PSMA-11 to enhance diagnosis of primary and metastatic prostate cancer; study completed with results p…

• CLINICAL_TRIALS trial_result · 2022-11-03
  Clinical Trial Update: Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL) [Phase 2]

  Phase 2 trial update evaluating maintenance olaparib in metastatic prostate cancer with partial or stable response after docetaxel.

• CLINICAL_TRIALS trial_result · 2021-03-02
  Clinical Trial Update: The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients [Phase 4]

  Phase 4 trial update investigating lipid reprogramming with rosuvastatin in castrated Egyptian patients with metastatic prostate cancer.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-10-09
  Clinical Trial Update: Selective Treatment According to Molecular Subtype of Prostate Cancer [Phase 2]

  A Phase 2 clinical trial update exploring selective treatment based on molecular subtype in prostate cancer, including castration-resistant …

• CLINICAL_TRIALS trial_result · 2017-06-12
  Clinical Trial Update: Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]

  Phase 2 trial comparing concurrent versus sequential sipuleucel-T and abiraterone in metastatic castration-resistant prostate cancer has com…